These results demonstrate that TRIM22 physically interacts with PHLPP2 and promotes its ubiquitin-mediated proteasomal degradation, ultimately leading to cellular senescence due to AKT activation in HCC cells. The gene discussed is AKT1; the disease is hepatocellular carcinoma.